• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC SWITZERLAND GMBH CENTRIMAG 2ND GENERATION PRIMARY CONSOLE; CONTROL, PUMP SPEED, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC SWITZERLAND GMBH CENTRIMAG 2ND GENERATION PRIMARY CONSOLE; CONTROL, PUMP SPEED, CARDIOPULMONARY BYPASS Back to Search Results
Model Number 201-90411
Device Problems Electrical /Electronic Property Problem (1198); Mechanical Problem (1384); Infusion or Flow Problem (2964)
Patient Problems No Consequences Or Impact To Patient (2199); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/23/2020
Event Type  malfunction  
Manufacturer Narrative
No additional information was provided.A supplemental report will be submitted when the manufacturer's investigation is completed.
 
Event Description
Related manufacturer¿s report # 2916596-2020-03880.It was reported that the patient experienced m2, f2 and b6 alarms during startup, with the motor plugged in.The site communicated that the console was plugged into the wall and powered on when the alarms visualized m2 motor disconnected, f2 flow signal interrupted.The motor was unplugged from the console, the prongs and cable inspected but no visual imperfections were noted.The site plugged the motor back in, and the m2 alarm was still present.The site inserted the training loop into the motor head, attached flow probe which resolved the f2 alarm.The site then removed motor from console, plugged in demo motor (not for patient use) visualized resolution of m2 alarm, increased rpms and confirmed properly functioning.
 
Manufacturer Narrative
Section d3: correction.
 
Manufacturer Narrative
Section d4: expiration date is not applicable for this device.Manufacturer's investigation conclusion: the reported event of m2 alarms were not confirmed; however, the reported f2 and b6 alarms were confirmed.The centrimag 2nd generation primary console (serial #: (b)(6) was returned for analysis and a log file was submitted for review.A review of the downloaded log fie showed events spanning approximately 7 days (b)(6) 2020, (b)(6) 2021 per time stamp).The reported event date was not captured within the log file.Events occurring on (b)(6) 2021 took place during lab testing at abbott.Several ¿flow signal interrupted: f2¿ were active throughout the log file.On (b)(6) 2020 at 16:21 a f2 alarm activates prior to a pump stop due to user request at 16:26.On (b)(6) 2021 following startup of the console at 17:32, a f2 alarm activated and cleared.At 17:35, a ¿flow signal interrupted: f2¿ activated again.All f2 alarms were able to be muted and cleared.Routine ¿on battery: b6¿ alarms were active throughout the log file when the console was operating on battery power.There were no other notable alarms active in the log file.The console evaluated and tested and the reported m2, f2, and b6 alarms observed at startup were not able to be confirmed during testing.The console was tested on a test loop for 72 hours with no alarms present.The console functioned as intended.The root cause for the reported alarms was unable to be conclusively determined through this analysis.The 2nd generation centrimag system operating manual section 4 entitled "warnings & precautions" warns "one additional 2nd generation centrimag primary console, motor and flow probe are required as backup system in the immediate vicinity of each patient whenever the centrimag or pedivas blood pump is used.The backup console must be connected to the backup motor and to the backup flow probe, have a battery charge sufficient for at least one hour of operation, be connected to ac power (except during transport) and be immediately available should the main console, motor or flow probe experience a malfunction." the 2nd generation centrimag system operating manual section 10 entitled "emergency and troubleshooting" states that "the recommended practice whenever there is a 2nd generation centrimag primary console or motor malfunction is to replace the console and motor as a set.Remove the blood pump from the malfunctioning motor and console and place the blood pump in the backup motor and console to continue patient support.Do not exchange individual motors or individual consoles during patient support." the 2nd generation centrimag system operating manual section 12.1 entitled "appendix i ¿ primary console alarms and alerts" contains a list of console alarms and alerts, as well as appropriate operator response to these events.The device history records were reviewed for the centrimag 2nd generation primary console (serial #: (b)(6), and the console was found to pass all manufacturing and qa specifications.No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CENTRIMAG 2ND GENERATION PRIMARY CONSOLE
Type of Device
CONTROL, PUMP SPEED, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
THORATEC SWITZERLAND GMBH
technoparkstrasse 1
zurich CA CH-80 05
SZ  CH-8005
MDR Report Key10390747
MDR Text Key202453443
Report Number2916596-2020-03881
Device Sequence Number1
Product Code DWA
UDI-Device Identifier07640135140702
UDI-Public07640135140702
Combination Product (y/n)N
PMA/PMN Number
K131179
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 03/22/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/31/2021
Device Model Number201-90411
Device Catalogue Number201-90411
Device Lot Number6804156
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/01/2021
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 07/23/2020
Initial Date FDA Received08/11/2020
Supplement Dates Manufacturer Received08/17/2020
03/16/2021
Supplement Dates FDA Received08/21/2020
03/22/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
CENTRIMAG MOTOR, US; CENTRIMAG MOTOR, US
-
-